- Home
- SHOO vs LIVN Comparison
SHOO vs LIVN Comparison
Compare SHOO & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SHOO | LIVN |
|---|---|---|
| Founded | 1990 | 1987 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Shoe Manufacturing | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.5B |
| IPO Year | 1993 | 1993 |
Fundamental Metrics
Financial Performance| Metric | SHOO | LIVN |
|---|---|---|
| Price | $43.03 | $63.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 8 |
| Target Price | $41.00 | ★ $65.00 |
| AVG Volume (30 Days) | ★ 960.3K | 572.1K |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | ★ 1.95% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.78 | N/A |
| Revenue | ★ $2,362,727,000.00 | $1,348,962,000.00 |
| Revenue This Year | $13.10 | $12.25 |
| Revenue Next Year | $11.74 | $6.75 |
| P/E Ratio | $55.13 | ★ N/A |
| Revenue Growth | 6.41 | ★ 8.63 |
| 52 Week Low | $19.05 | $32.48 |
| 52 Week High | $44.99 | $65.57 |
Technical Indicators
Market Signals| Indicator | SHOO | LIVN |
|---|---|---|
| Relative Strength Index (RSI) | 56.66 | 61.20 |
| Support Level | $42.45 | $62.59 |
| Resistance Level | $43.90 | $63.69 |
| Average True Range (ATR) | 1.03 | 1.31 |
| MACD | -0.35 | -0.33 |
| Stochastic Oscillator | 22.27 | 43.87 |
Price Performance
Historical ComparisonAbout SHOO Steven Madden Ltd.
Steven Madden Ltd designs and sells brand-name and private-label footwear and accessories. Its products are geared toward fashion-conscious adults and children. The company sells its products through department stores and other retailers as well as its stores and websites. The company's revenue comes from its operating segments: Wholesale Footwear, Wholesale Accessories or Apparel, Direct-to-Consumer, and Licensing. The wholesale footwear segment accounts for the majority of revenue.
About LIVN LivaNova PLC
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.